about
Posttransplant allosensitization in low immunological risk kidney and kidney-pancreas graft recipientsAdvanced Glycation End Products Evolution after Pancreas-Kidney Transplantation: Plasmatic and Cutaneous Assessments.Neutrophil gelatinase-associated lipocalin in kidney transplantation is an early marker of graft dysfunction and is associated with one-year renal function.End-stage renal disease versus death in a Portuguese cohort of elderly patients: an approach using competing event analysis.Leptin and adiponectin during the first week after kidney transplantation: biomarkers of graft dysfunction?The effect of delayed graft function on graft and patient survival in kidney transplantation: an approach using competing events analysis.Sarcopenia among hospitalized patients - A cross-sectional study.Impact of hepatitis C virus on renal transplantation: association with poor survival.Noncutaneous neoplasms after kidney transplantation: analysis at single center.Kidney and anemia in familial amyloidosis type I.The influence of HLA mismatches and immunosuppression on kidney graft survival: an analysis of more than 1300 patients.Hand length as an alternative measurement of height.Cardiovascular risk factors and events in pancreas-kidney transplants.Familial Amyloid Polyneuropathy treatment with Tafamidis – evaluation of one- and two-year treatment in Porto, Portugal.Immunosuppression with antithymocyte globulin in renal transplantation: better long-term graft survival.Peritoneal membrane evaluation in routine clinical practice.Peritoneal fast transport in incident peritoneal dialysis patients is not consistently associated with systemic inflammation.Psychopathological dimensions in subjects with hereditary ATTR V30M amyloidosis and their relation with life events due to the disease.Life paths of patients with transthyretin-related familial amyloid polyneuropathy Val30Met: a descriptive study.ESPEN diagnostic criteria for malnutrition - A validation study in hospitalized patients.Sarcopenia and length of hospital stay.Comparison of Jamar and Bodygrip Dynamometers for Handgrip Strength Measurement.Health-related quality of life may improve after transplantation in pancreas-kidney recipients.Determining donor-specific antibody C1q-binding ability improves the prediction of antibody-mediated rejection in human leucocyte antigen-incompatible kidney transplantation.Incorporating Scoring Risk Models for Care Planning of the Elderly with Chronic Kidney Disease.Role of de novo donor-specific anti-HLA antibodies in kidney graft failure: A case-control study.Usefulness of six diagnostic and screening measures for undernutrition in predicting length of hospital stay: a comparative analysis.Comparative analysis of undernutrition screening and diagnostic tools as predictors of hospitalisation costs.Handgrip strength measurement as a predictor of hospitalization costs.Handgrip strength cutoff values for undernutrition screening at hospital admission.Handgrip strength and associated factors in hospitalized patients.Impact assessment in living kidney donation: psychosocial aspects in the donor.Impact of pediatric kidney transplantation on long-term professional and social outcomes.Pancreatic autoantibodies after pancreas-kidney transplantation - do they matter?First-year renal function predicts long-term renal allograft loss.Low erythropoietin production in familial amyloidosis TTR V30M is not related with renal congophilic amyloid deposition. A clinicopathologic study of twelve cases.Liver transplantation and anemia in familial amyloidosis ATTR V30MEnd-stage renal disease and dialysis in hereditary amyloidosis TTR V30M: presentation, survival and prognostic factorsThe association between 25(OH)D levels, frailty status and obesity indices in older adultsEffects of Posture and Body Mass Index on Body Girth Assessment
P50
Q33563056-F777948B-D19A-46B3-80E9-BCDBF3603740Q36530332-3C723CAB-DF4D-4800-929F-1F530362BF14Q37322729-00DE017D-2C6B-4EB5-A9EF-2EF0E6E8F120Q38669268-90BDDBD5-2809-41E5-844E-A7CAE47C12E9Q40239838-1BDF600A-A62B-41B4-B4F8-D6F73BE92600Q41417223-3255AB0A-D1BE-4E3E-A48C-08D9110F5E66Q41597328-443C2A0C-6192-40A2-B909-726C6795CE5CQ43030585-0EF46D85-DE35-4F9A-BE9D-59AE3F904065Q43584805-0E582021-4BE8-457A-BDD4-9391B7DE5B53Q43797007-BBDB0749-6305-4B99-AF4B-96B11093D7A5Q44749664-C1E8E396-2794-4919-8055-DD8417C7DD45Q45166297-F519B485-6C4F-49C5-ABF4-52E315E08533Q45349327-30B3C521-6142-4F48-9C42-82FCD6189BFBQ45851627-B4574D39-0F56-40DF-8472-A9F68F13B856Q46719556-30D74F97-455B-47C6-93AF-AF1489B1139DQ46813522-8A31CC6F-70EC-4F73-8AA9-7BF36E403C48Q46839448-0278A0C0-D761-483F-B0E4-21F442E51CA7Q47550371-033364C6-78F1-4933-ABE2-13A65FFAAD29Q47593376-2058CF8D-51FD-41C8-BD1D-6B20408C1AFBQ47683957-F7DBF9E7-33F0-4702-AB7C-276362804359Q47940313-AA4E81F0-11C1-4BDB-AC33-0080D7246086Q47994587-76E8EE43-0F31-4C54-BA1C-38F515549406Q48053510-DF767694-C5DD-454C-8A09-6DEF050A94C2Q48255248-12CB7362-C11F-4A9A-AF1F-40A08F0C2DA0Q48275977-3B97D9AF-37A2-45D6-94D9-4C64978BCF91Q48290798-5FB3092A-C245-4E0D-901B-BFB36B5385FAQ50589885-4343256B-F146-4AEB-9F4C-B8A459B23100Q50599180-7FE81133-5CAB-4BCE-85E9-F5D985599C5FQ50616874-BF46AE63-6A88-4CFF-8862-A3492343063DQ50618851-B3C7E01E-76EC-438D-A905-D761A41E655AQ50674014-3533ABBB-678F-4782-A31E-EEFA80B46EB3Q50793080-9DDEF95A-E590-437E-8E8D-58D4978154A1Q51055227-94F16FAD-DAC5-48F8-ABD4-687508585693Q51325262-0C677ABC-6778-408A-B45C-91547E9A8879Q51502463-1B5AE5EA-DC9D-447D-B625-59734FFDCC0CQ54123131-1924C6A3-EE9D-4B2E-A6F5-0B453B0FE00FQ57526247-541CD1AC-D4F3-43B7-BADF-3A78F9424609Q57526268-9FB43CB6-FC6A-4714-BC32-5C677ADA4BA3Q58699939-EB06C9DD-EE9E-49D7-A630-F9A2BE80D2A0Q59677321-343C9559-0701-474D-887C-EC7CCF3D50C4
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Isabel Fonseca
@ast
Isabel Fonseca
@en
Isabel Fonseca
@es
Isabel Fonseca
@nl
Isabel Fonseca
@sl
type
label
Isabel Fonseca
@ast
Isabel Fonseca
@en
Isabel Fonseca
@es
Isabel Fonseca
@nl
Isabel Fonseca
@sl
prefLabel
Isabel Fonseca
@ast
Isabel Fonseca
@en
Isabel Fonseca
@es
Isabel Fonseca
@nl
Isabel Fonseca
@sl
P1053
K-6339-2013
P106
P1153
55941495000
P21
P2798
P31
P3829
P496
0000-0001-8984-1751
P569
2000-01-01T00:00:00Z